Cologne, Germany

Thomas Philipps


Average Co-Inventor Count = 8.1

ph-index = 9

Forward Citations = 434(Granted Patents)


Location History:

  • Colonge, DE (1990)
  • Koeln, DE (1991)
  • Koln, DE (1995 - 1996)
  • Cologne, DE (1991 - 2000)
  • late of Eupen, BE (2001)

Company Filing History:


Years Active: 1990-2001

Loading Chart...
26 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Thomas Philipps in Pharmaceutical Chemistry

Introduction

Thomas Philipps, based in Cologne, Germany, is a notable inventor in the field of pharmaceutical chemistry. He has an impressive portfolio with 26 patents that reflect his commitment to advancing medicinal compounds. His work primarily focuses on the development of novel compounds with potential therapeutic uses, showcasing his innovative approach to solving complex problems in medicine.

Latest Patents

Among his latest patents, one of the significant innovations includes the creation of substituted triols. These triols are synthesized by reducing appropriately substituted carboxylic esters and are poised to serve as active substances in various medicaments. Another remarkable invention involves 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone. This patent centers around intermediate compounds that facilitate the preparation of novel quinolone and naphthyridone derivatives. These derivatives are characterized by a partially hydrogenated isoindolinyl ring and are relevant in the development of antibacterial agents and feed additives.

Career Highlights

Thomas has carved a niche for himself at Bayer Aktiengesellschaft, a leading global company dedicated to advancing health and nutrition. His role in this esteemed organization reflects his expertise and dedication to innovation in pharmaceuticals. The contributions he has made significantly enhance Bayer's portfolio and underline the importance of research and development in the medicinal field.

Collaborations

Throughout his career, Thomas Philipps has collaborated with esteemed colleagues such as Rolf Angerbauer and Peter Fey. These partnerships emphasize the collaborative environment in which innovation flourishes, enabling the sharing of ideas and advancing research initiatives that can lead to groundbreaking discoveries.

Conclusion

In summary, Thomas Philipps has established himself as a prominent inventor in the pharmaceutical industry. His extensive patent portfolio and innovative contributions continue to impact the development of new therapeutic agents. By working at Bayer Aktiengesellschaft and collaborating with talented colleagues, he remains at the forefront of pharmaceutical innovation, driving advancements that can enhance health outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…